Skip to main content
. 2016 Jun 20;60(7):4315–4323. doi: 10.1128/AAC.00314-16

TABLE 3.

Periplasmic domain mutants achieved from in vitro random mutagenesis and their genotypes and associated resistance phenotypesa

AcrB region targeted by in vitro random mutagenesis AcrB mutation(s) Total no. of mutants with the indicated genotype Resistance phenotype
LP1 I38N G147D 1 DR
I38F A103T A160T 1 DR
I38F R259S 1 DR
I38F N144S A209E 1 DR
I38F 1 DR
I38S P116L A294V 1 DR
I38F P50L T196 M 1 DR
A22P T85A 1 Non-DR
Y35N 1 Non-DR
A39T 2 Non-DR
P224L F316S 1 Non-DR
P224T 1 Non-DR
T85A 1 Non-DR
LP2 T600I I671T A752V A831T 1 DR
I671T S813P A840T 1 DR
I671T 3 DR
N613S I671T E693D A831V 1 DR
I671T R699L S807P 1 DR
V672M 1 Non-DR
E673G 1 Non-DR
G621S K632R Q846H 1 Non-DR
L828F 1 Non-DR
L828S K835N 1 Non-DR
R586P G675A 1 Non-DR
R717S 1 Non-DR
K603R G621V M649V R717L F801L 1 Non-DR
a

See also Tables S1 and S2 in the supplemental material. Mutations exclusively occurring within DR phenotype mutants are depicted in boldface. For definitions of the DR (boldface) and non-DR phenotypes, see Table 2.